Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma (Q57141720)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 07 May 2018

Language	Label	Description	Also known as
English	Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma	scientific article published on 07 May 2018

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Shahrokh Shariat

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

Nirmish Singla

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Ahmet M Aydin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Vandana Panwar

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Solomon L Woldu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Yuval Freifeld

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Christopher G Wood

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Jose A Karam

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Alon Z Weizer

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Jay D Raman

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Mesut Remzi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Andrea Haitel

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Karim Bensalah

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Arthur I Sagalowsky

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Aditya Bagrodia

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Payal Kapur

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Vitaly Margulis

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Laura-Maria Krabbe

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Nathalie Rioux-Leclercq

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Christian Bolenz

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Yair Lotan

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

language of work or name

0 references

publication date

7 May 2018

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

343.e1-343.e8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

The Polycomb complex PRC2 and its mark in life

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

EZH2: an epigenetic gatekeeper promoting lymphomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Interplay between the cancer genome and epigenome

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

EZH2: biology, disease, and structure-based drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Roles of the EZH2 histone methyltransferase in cancer epigenetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Clinicopathological and prognostic significance of EZH2 expression in upper urinary tract carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Increased expression of EZH2, a polycomb group protein, in bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Urothelial carcinoma of the bladder and the upper tract: disparate twins

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Ureteral and Multifocal Tumours Have Worse Prognosis than Renal Pelvic Tumours in Urothelial Carcinoma of the Upper Urinary Tract Treated by Nephroureterectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Ureteral tumours showing a worse prognosis than renal pelvis tumours may be attributed to ureteral tumours more likely to have hydronephrosis and less likely to have haematuria

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Targeting the cancer epigenome for therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

7 January 2021

Identifiers

10.1016/J.UROLONC.2018.04.004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57141720&oldid=2223431320"